Cargando…

Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes

Lymph node metastasis is one of the most important prognostic indicators in patients with radically resected non-small cell lung cancer (NSCLC). This retrospective study aimed to compare the predictive value of metastatic lymph nodes (MNs), lymph node ratio (LNR), resected lymph nodes (RNs), and neg...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hongfeng, Yan, Tao, Zhang, Tiehong, Chen, Xiaowei, Wang, Yadong, Du, Jiajun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531103/
https://www.ncbi.nlm.nih.gov/pubmed/31096486
http://dx.doi.org/10.1097/MD.0000000000015645
_version_ 1783420756227522560
author Liu, Hongfeng
Yan, Tao
Zhang, Tiehong
Chen, Xiaowei
Wang, Yadong
Du, Jiajun
author_facet Liu, Hongfeng
Yan, Tao
Zhang, Tiehong
Chen, Xiaowei
Wang, Yadong
Du, Jiajun
author_sort Liu, Hongfeng
collection PubMed
description Lymph node metastasis is one of the most important prognostic indicators in patients with radically resected non-small cell lung cancer (NSCLC). This retrospective study aimed to compare the predictive value of metastatic lymph nodes (MNs), lymph node ratio (LNR), resected lymph nodes (RNs), and negative lymph nodes (NNs) with the currently used pathologic nodal (pN) staging category. We conducted a retrospective analysis of 1019 consecutive NSCLC patients treated with complete resection in a single institution. Prognostic values of various lymph node factors were evaluated by analysis of univariate and multivariate Cox proportional hazards model, and the results were compared with those using the location-based pN stage classification. The median follow-up duration was 47 months. During this period, 353 cases of cancer recurrence and 337 deaths were reported. Multivariate cox analysis indicated that both pN and NN categories were independent predictors of patient survival. The patients were divided into six groups on the basis of pN and NN categories. The survival rates of the groups were as follows: pN0, NN≥8, 81.4%; pN0, NN<8, 73.8%; pN1, NN≥8, 61.4%; pN1, NN<8, 54.2%; pN2, NN≥8, 48.4%; and pN2>1, NN<8, 35.0%. Comparison of the predictive values of the lymph node factors showed that the new N category was a more valuable prognostic factor in operable NSCLC. The combination of anatomically based pN stage classification and the number of MNs is an accurate prognostic determinant in patients with operable NSCLC which can be equal to 8th N category.
format Online
Article
Text
id pubmed-6531103
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-65311032019-06-25 Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes Liu, Hongfeng Yan, Tao Zhang, Tiehong Chen, Xiaowei Wang, Yadong Du, Jiajun Medicine (Baltimore) Research Article Lymph node metastasis is one of the most important prognostic indicators in patients with radically resected non-small cell lung cancer (NSCLC). This retrospective study aimed to compare the predictive value of metastatic lymph nodes (MNs), lymph node ratio (LNR), resected lymph nodes (RNs), and negative lymph nodes (NNs) with the currently used pathologic nodal (pN) staging category. We conducted a retrospective analysis of 1019 consecutive NSCLC patients treated with complete resection in a single institution. Prognostic values of various lymph node factors were evaluated by analysis of univariate and multivariate Cox proportional hazards model, and the results were compared with those using the location-based pN stage classification. The median follow-up duration was 47 months. During this period, 353 cases of cancer recurrence and 337 deaths were reported. Multivariate cox analysis indicated that both pN and NN categories were independent predictors of patient survival. The patients were divided into six groups on the basis of pN and NN categories. The survival rates of the groups were as follows: pN0, NN≥8, 81.4%; pN0, NN<8, 73.8%; pN1, NN≥8, 61.4%; pN1, NN<8, 54.2%; pN2, NN≥8, 48.4%; and pN2>1, NN<8, 35.0%. Comparison of the predictive values of the lymph node factors showed that the new N category was a more valuable prognostic factor in operable NSCLC. The combination of anatomically based pN stage classification and the number of MNs is an accurate prognostic determinant in patients with operable NSCLC which can be equal to 8th N category. Wolters Kluwer Health 2019-05-17 /pmc/articles/PMC6531103/ /pubmed/31096486 http://dx.doi.org/10.1097/MD.0000000000015645 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Liu, Hongfeng
Yan, Tao
Zhang, Tiehong
Chen, Xiaowei
Wang, Yadong
Du, Jiajun
Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes
title Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes
title_full Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes
title_fullStr Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes
title_full_unstemmed Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes
title_short Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes
title_sort proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531103/
https://www.ncbi.nlm.nih.gov/pubmed/31096486
http://dx.doi.org/10.1097/MD.0000000000015645
work_keys_str_mv AT liuhongfeng proposalofanewnodalclassificationforoperablenonsmallcelllungcancerbasedonthenumberofnegativelymphnodesandtheanatomicallocationofmetastaticlymphnodes
AT yantao proposalofanewnodalclassificationforoperablenonsmallcelllungcancerbasedonthenumberofnegativelymphnodesandtheanatomicallocationofmetastaticlymphnodes
AT zhangtiehong proposalofanewnodalclassificationforoperablenonsmallcelllungcancerbasedonthenumberofnegativelymphnodesandtheanatomicallocationofmetastaticlymphnodes
AT chenxiaowei proposalofanewnodalclassificationforoperablenonsmallcelllungcancerbasedonthenumberofnegativelymphnodesandtheanatomicallocationofmetastaticlymphnodes
AT wangyadong proposalofanewnodalclassificationforoperablenonsmallcelllungcancerbasedonthenumberofnegativelymphnodesandtheanatomicallocationofmetastaticlymphnodes
AT dujiajun proposalofanewnodalclassificationforoperablenonsmallcelllungcancerbasedonthenumberofnegativelymphnodesandtheanatomicallocationofmetastaticlymphnodes